© 1995 Oxford University Press
RESEARCH-ARTICLE |
Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444


Institut för Humangenetik, Universität Bonnn Wilhelmstr, 31, 53111 Bonn, Germany 1Laboratoire de Génétique des Tumeurs CJF9201 Rue d'Ulm, 75005 Paris, France 2Unité de Génétique Oncologique, Institut Curie Rue d'Ulm, 75005 Paris, France 3Augenklink Universitãt Bonn Sigmund-Freud-Str. 25, 53105 Bonn 4Chirurgische Klinik, Universität Heidelberg Im Neuenheimer Feld 110, 69120 Heidelberg 5Chirurgische Klinik, Universität Dösseldorf Moorenstr. 5, 40225 Düsseldorf, Germany
*To whom correspondence should be addressed
Received September 30, 1994; Revised December 22, 1994; Accepted December 22, 1994
An earlier study has shown that FAP patients with mutations in codons 136302 of the APC gene do not develop congenital hypertrophy of the retinal pigment epithelium (CHRPE), whereas those with mutations in codons 4631387 regularly do. Here we present data on 36 patients from 20 families with mutations in codons 14451578. These patients lack CHRPE. Furthermore, with the exception of three prepubertal children all patients with mutations in codons 14451578 developed desmoid tumours. This relationship between certain extracolonic manifestations and site of the APC mutation points to a specific role of the APC protein in different tissues.
These authors contributed equally to this work
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Feucht, L. Kluwe, V.-F. Mautner, and G. Richard Correlation of Nonsense and Frameshift Mutations With Severity of Retinal Abnormalities in Neurofibromatosis 2 Arch Ophthalmol, October 1, 2008; 126(10): 1376 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
H F A Vasen, G Moslein, A Alonso, S Aretz, I Bernstein, L Bertario, I Blanco, S Bulow, J Burn, G Capella, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP) Gut, May 1, 2008; 57(5): 704 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ezumi, H. Yamamoto, I. Takemasa, M. Nomura, M. Ikeda, M. Sekimoto, and M. Monden Dacarbazine-Doxorubicin Therapy Ameliorated an Extremely Aggressive Mesenteric Desmoid Tumor Associated with Familial Adenomatous Polyposis: Report of a Case Jpn. J. Clin. Oncol., March 1, 2008; 38(3): 222 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gega, H. Yanagi, R. Yoshikawa, M. Noda, H. Ikeuchi, K. Tsukamoto, T. Oshima, Y. Fujiwara, N. Gondo, K. Tamura, et al. Successful Chemotherapeutic Modality of Doxorubicin Plus Dacarbazine for the Treatment of Desmoid Tumors in Association With Familial Adenomatous Polyposis J. Clin. Oncol., January 1, 2006; 24(1): 102 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Renkonen, P. Nieminen, W. M. Abdel-Rahman, A.-L. Moisio, I. Jarvela, S. Arte, H. J. Jarvinen, and P. Peltomaki Adenomatous Polyposis Families That Screen APC Mutation-Negative by Conventional Methods Are Genetically Heterogeneous J. Clin. Oncol., August 20, 2005; 23(24): 5651 - 5659. [Abstract] [Full Text] [PDF] |
||||
![]() |
M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 J. Med. Genet., July 1, 2005; 42(7): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Aretz, D Stienen, S Uhlhaas, C Pagenstecher, E Mangold, R Caspari, P Propping, and W Friedl Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis J. Med. Genet., February 1, 2005; 42(2): 185 - 192. [Full Text] [PDF] |
||||
![]() |
N J H Sturt, M C Gallagher, P Bassett, C R Philp, K F Neale, I P M Tomlinson, A R J Silver, and R K S Phillips Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation Gut, December 1, 2004; 53(12): 1832 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Plawski, J Lubinski, T Banasiewicz, J Paszkowski, D Lipinski, A Strembalska, G Kurzawski, T Byrski, S Zajaczek, D Hodorowicz-Zaniewska, et al. Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis J. Med. Genet., January 1, 2004; 41(1): e11 - 11. [Full Text] [PDF] |
||||
![]() |
L. Bertario, A. Russo, P. Sala, L. Varesco, M. Giarola, P. Mondini, M. Pierotti, P. Spinelli, and P. Radice Multiple Approach to the Exploration of Genotype-Phenotype Correlations in Familial Adenomatous Polyposis J. Clin. Oncol., May 1, 2003; 21(9): 1698 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Parc, C Boisson, G Thomas, and S Olschwang Cancer risk in 348 French MSH2 or MLH1 gene carriers J. Med. Genet., March 1, 2003; 40(3): 208 - 213. [Full Text] [PDF] |
||||
![]() |
N. S. Fearnhead, M. P. Britton, and W. F. Bodmer The ABC of APC Hum. Mol. Genet., April 1, 2001; 10(7): 721 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J Scott, C Meldrum, R Crooks, A D Spigelman, J Kirk, K Tucker, D Koorey, and t. H. F. C. Service Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity Gut, April 1, 2001; 48(4): 508 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Friedl, R Caspari, M Sengteller, S Uhlhaas, C Lamberti, M Jungck, M Kadmon, M Wolf, J Fahnenstich, J Gebert, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families Gut, April 1, 2001; 48(4): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R HOULSTON, M CRABTREE, R PHILLIPS, M CRABTREE, and I TOMLINSON Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes Gut, January 1, 2001; 48(1): 1 - 5. [Full Text] [PDF] |
||||
![]() |
F. Cetta, M. C. Curia, G. Montalto, M. Gori, A. Cama, P. Battista, and A. Barbarisi Thyroid Carcinoma Usually Occurs in Patients with Familial Adenomatous Polyposis in the Absence of Biallelic Inactivation of the Adenomatous Polyposis Coli Gene J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 427 - 432. [Abstract] [Full Text] |
||||
![]() |
G. D. STRIZHEVA, T. CARSILLO, W. D. KRUGER, E. J. SULLIVAN, J. H. RYU, and E. P. HENSKE The Spectrum of Mutations in TSC1 and TSC2 in Women with Tuberous Sclerosis and Lymphangiomyomatosis Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 253 - 258. [Abstract] [Full Text] |
||||
![]() |
H. F. A. Vasen Clinical Diagnosis and Management of Hereditary Colorectal Cancer Syndromes J. Clin. Oncol., November 1, 2000; 18(90001): 81s - 92. [Full Text] [PDF] |
||||
![]() |
K. H. Goss and J. Groden Biology of the Adenomatous Polyposis Coli Tumor Suppressor J. Clin. Oncol., May 9, 2000; 18(9): 1967 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cetta, G. Montalto, M. Gori, M. C. Curia, A. Cama, and S. Olschwang Germline Mutations of the APC Gene in Patients with Familial Adenomatous Polyposis-Associated Thyroid Carcinoma: Results from a European Cooperative Study J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 286 - 292. [Abstract] [Full Text] |
||||
![]() |
F. Cetta, M. R. Pelizzo, M. C. Curia, and A. Barbarisi Genetics and Clinicopathological Findings in Thyroid Carcinomas Associated with Familial Adenomatous Polyposis Am. J. Pathol., July 1, 1999; 155(1): 7 - 9. [Full Text] [PDF] |
||||
![]() |
S. Dihlmann, J. Gebert, A. Siermann, C. Herfarth, and M. von Knebel Doeberitz Dominant Negative Effect of the APC1309 Mutation: A Possible Explanation for Genotype-Phenotype Correlations in Familial Adenomatous Polyposis Cancer Res., April 1, 1999; 59(8): 1857 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Laken, N. Papadopoulos, G. M. Petersen, S. B. Gruber, S. R. Hamilton, F. M. Giardiello, J. D. Brensinger, B. Vogelstein, and K. W. Kinzler Analysis of masked mutations in familial adenomatous polyposis PNAS, March 2, 1999; 96(5): 2322 - 2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kartheuser, C. Walon, S. West, C. Breukel, R. Detry, A.-C. Gribomont, T. Hamzehloei, P. Hoang, D. Maiter, J. Pringot, et al. Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3' APC mutation J. Med. Genet., January 1, 1999; 36(1): 65 - 67. [Abstract] [Full Text] |
||||
![]() |
C. Soravia, S. L. Sugg, T. Berk, A. Mitri, H. Cheng, S. Gallinger, Z. Cohen, S. L. Asa, and B. V. Bapat Familial Adenomatous Polyposis-Associated Thyroid Cancer : A Clinical, Pathological, and Molecular Genetics Study Am. J. Pathol., January 1, 1999; 154(1): 127 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Heinimann, B Mullhaupt, W Weber, M Attenhofer, R J Scott, M Fried, S Martinoli, H. Muller, and Z Dobbie Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status Gut, November 1, 1998; 43(5): 675 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D Brensinger, S J Laken, M C Luce, S M Powell, G H Vance, D J Ahnen, G M Petersen, S R Hamilton, and F M Giardiello Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene Gut, October 1, 1998; 43(4): 548 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H T LYNCH and P WATSON AFAP: variety is the spice of life Gut, October 1, 1998; 43(4): 451a - 451. [Full Text] |
||||
![]() |
D M Eccles, P W Lunt, Y Wallis, M Griffiths, B Sandhu, S McKay, D Morton, J Shea-Simonds, and F MacDonald An unusually severe phenotype for familial adenomatous polyposis Arch. Dis. Child., November 1, 1997; 77(5): 431 - 435. [Abstract] [Full Text] |
||||
![]() |
B A Leggett, J P Young, K Biden, R L Buttenshaw, N Knight, and A E Cowen Severe upper gastrointestinal polyposis associated with sparse colonic polyposis in a familial adenomatous polyposis family with an APC mutation at codon 1520 Gut, October 1, 1997; 41(4): 518 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
F CETTA, G MONTALTO, and M PETRACCI Hepatoblastoma and APC gene mutation in familial adenomatous polyposis Gut, September 1, 1997; 41(3): 417 - 420. [Full Text] [PDF] |
||||
![]() |
A. Tiret, M. Taiel-Sartral, E. Tiret, and L. Laroche Diagnostic value of fundus examination in familial adenomatous polyposis Br J Ophthalmol, September 1, 1997; 81(9): 755 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Marcus, A. K. Rustgi, D. Defoe, S. E. Brooks, R. S. McCormick, T. P. Thompson, W. Edelmann, R. Kucherlapati, and S. Smith Retinal Pigment Epithelium Abnormalities in Mice With Adenomatous Polyposis Coli Gene Disruption Arch Ophthalmol, May 1, 1997; 115(5): 645 - 650. [Abstract] [PDF] |
||||












